Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07115563 · ClinicalTrials.gov registry record · NA
Daily Amino Acid Supplementation for People With Parkinson's Disease
A NA study of Parkinson Disease (PD), sponsored by Cristina Colon-Semenza.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07115563 is a NA study of Parkinson Disease (PD) that is actively recruiting participants, run by Cristina Colon-Semenza. The registered enrollment target is 30 participants, roughly in line with the 32-participant average among 3 other Parkinson Disease (PD) trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT07115563, a NA study of Parkinson Disease (PD), is actively recruiting participants, sponsored by Cristina Colon-Semenza.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if a tailored amino acid supplement works to help adults living with Parkinson's disease to improve nutrition, metabolic function, body composition, and physical and mental function. The main questions it aims to answer are: Does the tailored amino acid supplement increase essential amino acids (nutritional status)? Does the tailored amino acid supplement increase an antioxidant (complex amino acid) and decrease an amino acid associated with oxidative stress? Does the tailored amino acid supplement improve physical and mental health compared to a placebo supplement? Researchers will compare the tailored amino acid supplement to a placebo (a look-alike substance that contains no active ingredients) to see if the tailored amino acid supplements work to support health for people with Parkinson's disease. Participants will: Take the tailored amino acid supplement or a placebo every day for 6 months, visit the lab at baseline, after 3 months, and after 6 months for fasting blood draws, body composition assessment, and physical and mental health testing and keep a diary of their food intake and supplement intake.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Control (placebo)
- DIETARY_SUPPLEMENT Targeted Amino Acid Supplement
Study Locations (1)
Connecticut
- University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-10-31 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07115563
The ClinicalTrials.gov registry entry for NCT07115563 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 32-participant average among 3 other Parkinson Disease (PD) trials with a reported enrollment target. The listed sponsor is Cristina Colon-Semenza, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease (PD) appearing as the primary indexed condition, and to 2 interventions - of which Control (placebo) is the first listed.
NCT07115563 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT07115563 about?
NCT07115563 is a clinical study titled "Daily Amino Acid Supplementation for People With Parkinson's Disease". The goal of this clinical trial is to learn if a tailored amino acid supplement works to help adults living with Parkinson's disease to improve nutrition, metabolic function, body composition, and physical and mental function. The main questions it aims to answer are: Does the tailored amino acid s...
What is the current status of trial NCT07115563?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-10-31. Estimated completion is 2027-11.
What conditions does trial NCT07115563 study?
This clinical trial studies the following conditions: Parkinson Disease (PD).
What interventions are being tested in trial NCT07115563?
The interventions under investigation include: Control (placebo) (DIETARY_SUPPLEMENT), Targeted Amino Acid Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07115563?
This trial is sponsored by Cristina Colon-Semenza, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07115563 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease (PD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.